FluMist Rejuvenated With CDC Advisory Panel Endorsement; Effectiveness Data Still To Come
US panel votes 12 to 2 to recommend use of nasal vaccine, which has been reformulated to include a new influenza A strain.
US panel votes 12 to 2 to recommend use of nasal vaccine, which has been reformulated to include a new influenza A strain.